-
Genflow Biosciences Advances Key AAV Longevity Programs GF-1002 and GF-1004
Jul 24 2025 -
Pierre Fabre Pharmaceuticals and Atara Biotherapeutics Advance Cell Therapy with FDA Priority Review
Jul 24 2025 -
Solid Biosciences’ AAV Gene Therapy SGT-501 Granted FDA Fast Track for CPVT
Jul 23 2025 -
Dispatch Bio Emerges from Stealth with $216M to Tackle Solid Tumors with Novel In Vivo CAR-T Approach
Jul 23 2025 -
Precision BioSciences Receives FDA Orphan Drug Designation for AAV Gene Therapy PBGENE-DMD
Jul 23 2025 -
Opus Genetics Partners with Global RDH12 Alliance to Accelerate Gene Therapy for IRDs
Jul 23 2025 -
Sarepta Pauses DMD Gene Therapy Shipments Following FDA Request
Jul 22 2025 -
CBO Report: NIH Cuts and FDA Delays Could Significantly Reduce New Drug Development
Jul 22 2025 -
Orbital Therapeutics Unveils Preclinical Data for In Vivo Circular RNA CAR-T in Autoimmune Disease
Jul 22 2025